Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients

Xuemei Zhen^{1

2}, Cecilia Stålsby Lundborg³, Xueshan Sun¹, Nina Zhu⁴, Shuyan Gu^{1

5}, Hengjin Dong^{6

7}

Affiliations

¹ Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
² Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine (NHC Key Laboratory of Health Economics and Policy Research), Shandong University, Jinan, 250012, China.
³ Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
⁴ National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance (HCAIs & AMR), Department of Infectious Disease, Imperial College, London, UK.
⁵ Center for Health Policy and Management Studies, Nanjing University, Nanjing, China.
⁶ Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China. donghj@zju.edu.cn.
⁷ The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, China. donghj@zju.edu.cn.

Published Erratum

Xuemei Zhen et al. Antimicrob Resist Infect Control. 2021.

. 2021 Apr 1;10(1):64.

doi: 10.1186/s13756-021-00934-7.

Xuemei Zhen^{1

2}, Cecilia Stålsby Lundborg³, Xueshan Sun¹, Nina Zhu⁴, Shuyan Gu^{1

5}, Hengjin Dong^{6

7}

¹ Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
² Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine (NHC Key Laboratory of Health Economics and Policy Research), Shandong University, Jinan, 250012, China.
³ Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
⁴ National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance (HCAIs & AMR), Department of Infectious Disease, Imperial College, London, UK.
⁵ Center for Health Policy and Management Studies, Nanjing University, Nanjing, China.
⁶ Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China. donghj@zju.edu.cn.
⁷ The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, China. donghj@zju.edu.cn.

No abstract available

Erratum for

Economic burden of antibiotic resistance in China: a national level estimate for inpatients.
Zhen X, Stålsby Lundborg C, Sun X, Zhu N, Gu S, Dong H. Zhen X, et al. Antimicrob Resist Infect Control. 2021 Jan 6;10(1):5. doi: 10.1186/s13756-020-00872-w. Antimicrob Resist Infect Control. 2021. PMID: 33407856 Free PMC article.

Risk factors and predictive model for nosocomial infections by extensively drug-resistant Acinetobacter baumannii.
Shi J, Mao X, Cheng J, Shao L, Shan X, Zhu Y. Shi J, et al. Front Cell Infect Microbiol. 2024 Sep 30;14:1475428. doi: 10.3389/fcimb.2024.1475428. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39403207 Free PMC article.

1. Zhen X, et al. Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrob Resist Infect Control. 2021;10:5. doi: 10.1186/s13756-020-00872-w. - DOI - PMC - PubMed